These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2038413)

  • 1. [Antitumor effect of direct intra-tumor administration of OK-432 on malignant glioma: basic and clinical observations].
    Fujisawa K; Kanno T; Yokoi K; Onouchi K; Kawase T; Abe M
    No Shinkei Geka; 1991 Mar; 19(3):241-6. PubMed ID: 2038413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antitumor efficacy of activated macrophages against murine glioma cells].
    Miyao Y; Shimizu K; Okamoto Y; Matsui Y; Ushio Y; Hayakawa T; Tsuda N; Mogami H
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2082-8. PubMed ID: 3717955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antitumor effect of intra-arterial tumor necrosis factor-alpha in rats with transplanted intracerebral glioma and its evaluation by MRI].
    Harada K; Yoshida J; Wakabayashi T; Sugita K; Kurisu K; Uozumi T; Zieroth BF; Takahashi M; Yamanaka T
    No Shinkei Geka; 1995 Dec; 23(12):1069-74. PubMed ID: 8927213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Local immunotherapy with OK-432 for malignant gliomas--immunohistochemical analysis of chronological changes of tumor tissues].
    Saito T; Tanaka R; Sekiguchi K; Yoshida S; Washiyama K; Yamada N; Takeda N
    No To Shinkei; 1988 Jul; 40(7):609-15. PubMed ID: 3224036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of combined use of radiation and twice intratumor administration of OK-432 at one week intervals against a murine fibrosarcoma (NFSA)].
    Mukai M; Ando K; Koike S
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):631-5. PubMed ID: 3355184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation of serial MRI and histological findings following intra-tumor local chemotherapy for malignant brain tumor].
    Shimura T; Nakazawa S; Takahashi H; Node Y; Tamai J; Kumazaki T
    Gan To Kagaku Ryoho; 1994 Feb; 21(2):209-18. PubMed ID: 8311491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Locoregional immunotherapy of malignant ascites from gastric cancer using DTH-oriented doses of the streptococcal preparation OK-432: Treatment of Th1 dysfunction in the ascites microenvironment.
    Yamaguchi Y; Ohshita A; Kawabuchi Y; Hihara J; Miyahara E; Noma K; Toge T
    Int J Oncol; 2004 Apr; 24(4):959-66. PubMed ID: 15010836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential usefulness of a cultured glioma cell line induced by Rous sarcoma virus in B10.A mouse as an immunotherapy model.
    Sakamoto K; Hoshino H; Kiuchi Y; Nakano G; Nagamachi Y
    Jpn J Exp Med; 1989 Oct; 59(5):173-80. PubMed ID: 2559217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemotherapy for experimental subarachnoid dissemination model of brain tumor].
    Yamashita T; Shinonaga M; Ishiwata Y; Nishimura S; Murai M; Kyuma Y; Kuwabara T
    No Shinkei Geka; 1984 Jan; 12(1):47-53. PubMed ID: 6585681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-tumor effect of hyperthermia plus hematoporphyrin derivative on malignant brain tumor].
    Hondo H
    No To Shinkei; 1988 May; 40(5):477-84. PubMed ID: 3415865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The management of malignant ascites with a streptococcal preparation, OK-432: relation between the clinical effect and auto-tumor cell killing activity by OK-432-induced ascites-derived lymphocytes].
    Katano M; Yamamoto H; Mizoguchi T; Hidaka K; Hisatsugu T; Torisu M
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2464-8. PubMed ID: 3497612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-tumor activity of human recombinant TNF against human malignant glioma cell lines and combined effect with Hu INF-beta].
    Enomoto H; Yoshida J; Kageyama N; Ueda R; Kato T; Ota K
    Gan To Kagaku Ryoho; 1986 May; 13(5):1953-61. PubMed ID: 3085596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhalation therapy using a streptococcal preparation (OK-432) against bronchioloalveolar carcinoma of the lung.
    Yano T; Ichinose Y; Yokoyama H; Fukuyama Y; Sugio K; Sugimachi K
    Anticancer Res; 1999; 19(6C):5511-4. PubMed ID: 10697608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial.
    Yamanaka R; Homma J; Yajima N; Tsuchiya N; Sano M; Kobayashi T; Yoshida S; Abe T; Narita M; Takahashi M; Tanaka R
    Clin Cancer Res; 2005 Jun; 11(11):4160-7. PubMed ID: 15930352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Histopathological and autoradiographical studies of experimental brain tumors after continuous local chemotherapy--acute stage in rat models].
    Shimura T; Teramoto A; Aihara K
    Gan To Kagaku Ryoho; 1997 Apr; 24(6):713-8. PubMed ID: 9126309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated herpes simplex virus thymidine kinase gene therapy in BT4C rat glioma model.
    Tyynelä K; Sandmair AM; Turunen M; Vanninen R; Vainio P; Kauppinen R; Johansson R; Vapalahti M; Ylä-Herttuala S
    Cancer Gene Ther; 2002 Nov; 9(11):917-24. PubMed ID: 12386830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prophylactic therapy for liver metastasis of gastrointestinal carcinomas using biological response modifiers (BRM): fundamental studies on the inhibition of experimental liver metastasis by intraportal administration of OK-432].
    Kasagi T; Tazawa K; Yamashita I; Ishizawa S; Masuyama K; Fujimaki M; Maeda M
    Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):112-20. PubMed ID: 2324583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention of peritoneal recurrence by combined intra-peritoneal and intra-tumoral injections of OK-432].
    Baba H; Tsujitani S; Korenaga D; Kakeji Y; Haraguchi M; Konoe S; Maehara Y; Sugimachi K
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1596-9. PubMed ID: 2389954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of intratumoral administration of tumor necrosis factor-alpha in patients with malignant glioma.
    Oshiro S; Tsugu H; Komatsu F; Ohnishi H; Ueno Y; Sakamoto S; Fukushima T; Soma G
    Anticancer Res; 2006; 26(6A):4027-32. PubMed ID: 17195453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vesicular stomatitis virus G pseudotyped retrovector mediates effective in vivo suicide gene delivery in experimental brain cancer.
    Galipeau J; Li H; Paquin A; Sicilia F; Karpati G; Nalbantoglu J
    Cancer Res; 1999 May; 59(10):2384-94. PubMed ID: 10344748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.